Exjade is the first ORAL iron-chelation therapy
Exjade is the first ORAL iron-chelation therapy.
Exjade will be used in patients who develop iron overload from blood transfusions for sickle cell disease, thalassemia, etc...to prevent toxicity from high iron levels.
Until now, getting rid of excess iron required numerous Desferal (deferoxamine) infusions...but these can be very inconvenient.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote